157 related articles for article (PubMed ID: 32745207)
1. Molecular Profiling of Thyroid Nodules-Are These Findings Meaningful, or Merely Measurable?: A Review.
Morris LGT
JAMA Otolaryngol Head Neck Surg; 2020 Sep; 146(9):845-850. PubMed ID: 32745207
[TBL] [Abstract][Full Text] [Related]
2. Cost-effectiveness of a novel molecular test for cytologically indeterminate thyroid nodules.
Li H; Robinson KA; Anton B; Saldanha IJ; Ladenson PW
J Clin Endocrinol Metab; 2011 Nov; 96(11):E1719-26. PubMed ID: 21865367
[TBL] [Abstract][Full Text] [Related]
3. Performance of a Multigene Genomic Classifier in Thyroid Nodules With Indeterminate Cytology: A Prospective Blinded Multicenter Study.
Steward DL; Carty SE; Sippel RS; Yang SP; Sosa JA; Sipos JA; Figge JJ; Mandel S; Haugen BR; Burman KD; Baloch ZW; Lloyd RV; Seethala RR; Gooding WE; Chiosea SI; Gomes-Lima C; Ferris RL; Folek JM; Khawaja RA; Kundra P; Loh KS; Marshall CB; Mayson S; McCoy KL; Nga ME; Ngiam KY; Nikiforova MN; Poehls JL; Ringel MD; Yang H; Yip L; Nikiforov YE
JAMA Oncol; 2019 Feb; 5(2):204-212. PubMed ID: 30419129
[TBL] [Abstract][Full Text] [Related]
4. Targeted Next Generation Sequencing with ThyroSeq v2.1 for Indeterminate Thyroid Nodules in Clinical Practice.
Witt RL
Del Med J; 2016 Dec; 88(12):366-372. PubMed ID: 29461717
[TBL] [Abstract][Full Text] [Related]
5. Cost analysis of reflexive versus selective molecular testing for indeterminate thyroid nodules.
Hu QL; Schumm MA; Zanocco KA; Yeh MW; Livhits MJ; Wu JX
Surgery; 2022 Jan; 171(1):147-154. PubMed ID: 34284895
[TBL] [Abstract][Full Text] [Related]
6. Update on Molecular Testing for Cytologically Indeterminate Thyroid Nodules.
Nishino M; Nikiforova M
Arch Pathol Lab Med; 2018 Apr; 142(4):446-457. PubMed ID: 29336606
[TBL] [Abstract][Full Text] [Related]
7. Overview of molecular biomarkers for enhancing the management of cytologically indeterminate thyroid nodules and thyroid cancer.
Duick DS
Endocr Pract; 2012; 18(4):611-5. PubMed ID: 22849877
[TBL] [Abstract][Full Text] [Related]
8. Current use of molecular profiling for indeterminate thyroid nodules.
López Rojo I; Gómez Valdazo A; Gómez Ramirez J
Cir Esp (Engl Ed); 2018; 96(7):395-400. PubMed ID: 29779608
[TBL] [Abstract][Full Text] [Related]
9. Performance of a Genomic Sequencing Classifier for the Preoperative Diagnosis of Cytologically Indeterminate Thyroid Nodules.
Patel KN; Angell TE; Babiarz J; Barth NM; Blevins T; Duh QY; Ghossein RA; Harrell RM; Huang J; Kennedy GC; Kim SY; Kloos RT; LiVolsi VA; Randolph GW; Sadow PM; Shanik MH; Sosa JA; Traweek ST; Walsh PS; Whitney D; Yeh MW; Ladenson PW
JAMA Surg; 2018 Sep; 153(9):817-824. PubMed ID: 29799911
[TBL] [Abstract][Full Text] [Related]
10. Afirma Gene Sequencing Classifier Compared with Gene Expression Classifier in Indeterminate Thyroid Nodules.
Endo M; Nabhan F; Porter K; Roll K; Shirley LA; Azaryan I; Tonkovich D; Perlick J; Ryan LE; Khawaja R; Meng S; Phay JE; Ringel MD; Sipos JA
Thyroid; 2019 Aug; 29(8):1115-1124. PubMed ID: 31154940
[No Abstract] [Full Text] [Related]
11. Effect of Gene Expression Classifier Molecular Testing on the Surgical Decision-Making Process for Patients With Thyroid Nodules.
Noureldine SI; Olson MT; Agrawal N; Prescott JD; Zeiger MA; Tufano RP
JAMA Otolaryngol Head Neck Surg; 2015 Dec; 141(12):1082-8. PubMed ID: 26606459
[TBL] [Abstract][Full Text] [Related]
12. Value of Molecular Tests in Cytologically Indeterminate Lesions of Thyroid.
Zhang X
Arch Pathol Lab Med; 2015 Dec; 139(12):1484-90. PubMed ID: 26619020
[TBL] [Abstract][Full Text] [Related]
13. An update on the status of molecular testing for the indeterminate thyroid nodule and risk stratification of differentiated thyroid cancer.
Nicholson KJ; Yip L
Curr Opin Oncol; 2018 Jan; 30(1):8-15. PubMed ID: 29028645
[TBL] [Abstract][Full Text] [Related]
14. Thyroid Nodule Molecular Testing: Is It Ready for Prime Time?
Khan TM; Zeiger MA
Front Endocrinol (Lausanne); 2020; 11():590128. PubMed ID: 33162941
[TBL] [Abstract][Full Text] [Related]
15. Molecular diagnostic testing and the indeterminate thyroid nodule.
Yip L
Curr Opin Oncol; 2014 Jan; 26(1):8-13. PubMed ID: 24225416
[TBL] [Abstract][Full Text] [Related]
16. Update on Molecular Testing for Cytologically Indeterminate Thyroid Nodules.
Bose S; Sacks W; Walts AE
Adv Anat Pathol; 2019 Mar; 26(2):114-123. PubMed ID: 30664001
[TBL] [Abstract][Full Text] [Related]
17. Centralized molecular testing for oncogenic gene mutations complements the local cytopathologic diagnosis of thyroid nodules.
Beaudenon-Huibregtse S; Alexander EK; Guttler RB; Hershman JM; Babu V; Blevins TC; Moore P; Andruss B; Labourier E
Thyroid; 2014 Oct; 24(10):1479-87. PubMed ID: 24811481
[TBL] [Abstract][Full Text] [Related]
18. Preoperative diagnosis of benign thyroid nodules with indeterminate cytology.
Alexander EK; Kennedy GC; Baloch ZW; Cibas ES; Chudova D; Diggans J; Friedman L; Kloos RT; LiVolsi VA; Mandel SJ; Raab SS; Rosai J; Steward DL; Walsh PS; Wilde JI; Zeiger MA; Lanman RB; Haugen BR
N Engl J Med; 2012 Aug; 367(8):705-15. PubMed ID: 22731672
[TBL] [Abstract][Full Text] [Related]
19. Interinstitutional variation in predictive value of the ThyroSeq v2 genomic classifier for cytologically indeterminate thyroid nodules.
Marcadis AR; Valderrabano P; Ho AS; Tepe J; Swartzwelder CE; Byrd S; Sacks WL; Untch BR; Shaha AR; Xu B; Lin O; Ghossein RA; Wong RJ; Marti JL; Morris LGT
Surgery; 2019 Jan; 165(1):17-24. PubMed ID: 30360906
[TBL] [Abstract][Full Text] [Related]
20. ACR TI-RADS and ATA US scores are helpful for the management of thyroid nodules with indeterminate cytology.
Barbosa TLM; Junior COM; Graf H; Cavalvanti T; Trippia MA; da Silveira Ugino RT; de Oliveira GL; Granella VH; de Carvalho GA
BMC Endocr Disord; 2019 Oct; 19(1):112. PubMed ID: 31664992
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]